F.L. Putnam Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,923
Closed -$269K 583
2024
Q4
$269K Buy
2,923
+102
+4% +$9.81K ﹤0.01% 504
2024
Q3
$262K Buy
2,821
+117
+4% +$10.1K ﹤0.01% 513
2024
Q2
$222K Buy
+2,704
New +$199K ﹤0.01% 520

Other funds holding LMAT

F.L. Putnam Investment Management's LMAT Position: Q1 2025 in Review

F.L. Putnam Investment Management sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 2,923 shares — an estimated $269K sold.

F.L. Putnam Investment Management first reported a position in LMAT in Q2 2024 and held it in 3 quarters. The position peaked at $269K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • F.L. Putnam Investment Management reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • F.L. Putnam Investment Management sold 2,923 LeMaitre Vascular shares in Q1 2025, an estimated $269K.
  • F.L. Putnam Investment Management first reported a position in LeMaitre Vascular in Q2 2024 and held it in 3 quarters.
  • F.L. Putnam Investment Management's LeMaitre Vascular position peaked at $269K in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2025, filed 15 May 2025.